From: Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma
Group | n | Cyclin D1 | χ2 test | comparison of Cyclin D1 positive rates | ||||
---|---|---|---|---|---|---|---|---|
Positive | Negative | Positive rate(%) | PTC VS Adjacent | PTC VS FA | PTC VS PH | |||
Adjacent | 200 | 0 | 200 | 0.00 | χ2 | 347.66 | 12.55 | 128.67 |
Papillary thyroid carcinoma | 200 | 186 | 14 | 93.00 | ||||
Follicular adenoma | 39 | 10 | 29 | 25.64 | P | 0.000 | 0.000 | 0.000 |
Papillary hyperplasia | 40 | 1 | 39 | 2.50 | ||||
Group | n | P21 | χ2 test | comparison of P21 positive rates | ||||
Positive | Negative | Positive rate(%) | PTC VS Adjacent | PTC VS FA | PTC VS PH | |||
Adjacent | 200 | 0 | 200 | 0.00 | χ2 | 317.49 | 120.65 | 134.86 |
Papillary thyroid carcinoma | 200 | 177 | 23 | 88.50 | ||||
Follicular adenoma | 39 | 2 | 37 | 5.13 | P | 0.000 | 0.000 | 0.000 |
Papillary hyperplasia | 40 | 0 | 40 | 0.00 |